Why is Nath Bio-Genes falling/rising?

As of 22-Jul, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at Rs 190.00, which reflects a decrease of Rs 6.95 or 3.53%. The stock has been underperforming, having fallen consecutively over the last two days with a total decline of 3.99%. It has also underperformed its sector by 3.14% today. Over the past week, the stock has decreased by 6.75%, and its one-year return stands at -18.59%, indicating consistent underperformance against the benchmark indices. The stock's valuation appears attractive with a low Price to Book Value of 0.6, but it has shown weak long-term fundamental strength, with a negative CAGR growth in operating profits over the last five years.
In the broader market context, the Sensex has only decreased by 0.47% over the past week, highlighting that Nath Bio-Genes' decline is more pronounced than the overall market trend. The stock's performance has been notably poor compared to the benchmark, with negative returns across multiple time frames, including a significant drop of 49.26% over the last five years. This underperformance is compounded by a lack of investor participation, as evidenced by a drastic fall in delivery volume. Despite a slight increase in profits over the past year, the overall sentiment remains negative due to the company's low profitability metrics and consistent underperformance against its peers.